Evaluation of plasma levels of BDNF in patients with disorder depressive

被引：1
|
作者：
Galletta, D. [1 ]
Mazzarino, C. [1 ]
Cusumano, G. [1 ]
Santoro, A. [1 ]
机构：
[1] Federico II Univ Hosp Naples, Dept Head Neck Care, Unit Psychiat & Psychol, Naples, Italy
来源：
EUROPEAN PSYCHIATRY | 2021年 / 64卷
关键词：
Depressive Disorder; plasma level; BDNF;
D O I：
10.1192/j.eurpsy.2021.898
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0543
引用
收藏
页码：S335 / S335
页数：1
相关论文
共 50 条
  • [31] Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study
    An, Ji Hyun
    Jang, Eun Hye
    Kim, Ah Young
    Fava, Maurizio
    Mischoulon, David
    Papakostas, George I.
    Na, Eun Jin
    Jang, Jihoon
    Yu, Han Young
    Hong, Jin Pyo
    Jeon, Hong Jin
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 259 : 349 - 354
  • [32] Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder
    Salehi, Iraj
    Hosseini, Seyed Mohammad
    Haghighi, Mohammad
    Jahangard, Leila
    Bajoghli, Hafez
    Gerber, Markus
    Puehse, Uwe
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 76 : 1 - 8
  • [33] Investigation of Irisin Levels in Patients with Major Depressive Disorder
    Okumus, Burak
    Pusuroglu, Meltem
    Baltacioglu, Mehmet
    Bahceci, Ilkay
    Bahceci, Buelent
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2024, 14 (01): : 40 - 47
  • [34] Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder
    Ai, Ming
    Wang, Jun
    Chen, Jianmei
    Wang, Wo
    Xu, Xiaoming
    Gan, Yao
    Li, Xuemei
    Gou, Xinyuan
    Cao, Jun
    Lv, Zhen
    Chen, Xiaorong
    Wang, Hengguang
    Ma, Qing
    Kuang, Li
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2019, 12 : 97 - 106
  • [35] Serum BDNF levels and intensity of depressive symptoms
    Filus, Jakub
    Rybakowski, Janusz
    NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA, 2010, 5 (3-4): : 155 - 162
  • [36] Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD)
    Katsuki, Asuka
    Yoshimura, Reiji
    Kishi, Taro
    Hori, Hikaru
    Umene-Nakano, Wakako
    Ikenouchi-Sugita, Atsuko
    Hayashi, Kenji
    Atake, Kiyokazu
    Iwata, Nakao
    Nakamura, Jun
    CNS SPECTRUMS, 2012, 17 (03) : 155 - 163
  • [37] Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
    Hidese, Shinsuke
    Yoshida, Fuyuko
    Ishida, Ikki
    Matsuo, Junko
    Hattori, Kotaro
    Kunugi, Hiroshi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2023, 43 (01) : 57 - 68
  • [38] Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine
    Ghosh, R.
    Gupta, R.
    Bhatia, M. S.
    Tripathi, A. K.
    Gupta, L. K.
    ASIAN JOURNAL OF PSYCHIATRY, 2015, 18 : 37 - 41
  • [39] BDNF plasma level changes after transcranial direct current stimulation in major depressive disorder
    Palm, U.
    Fintescu, Z.
    Schiller, C.
    Reisinger, E.
    Keeser, D.
    Bondy, B.
    Padberg, F.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 235 - 235
  • [40] Cardiac autonomic tone, plasma BDNF levels and paroxetine response in newly diagnosed patients of generalised anxiety disorder
    Dutt, Ravi
    Shankar, Nilima
    Srivastava, Shruti
    Yadav, Asha
    Ahmed, Rafat S.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2020, 24 (02) : 135 - 142
12345